• Immunetherapy in advanced BTC: Yes/No
• Which agent?
• Patient selection/tumour location?
• Role of maintenance therapy?
• Role of liquid biopsy/biomarker assessment

Moderator: Dr. Mohammed Algarni

panel:

• Role of laparoscopy assessment before perioperative therapy?
• What to do in patients with poor response to neoadjuvant therapy?
• Role of biomarkers e.g MSI in decision-making before perioperative therapy?
• Patients with limited peritoneal metastasis: Role of HIPEC?
• Role of immunetherapy with perioperative therapy non-metastatic gastric cancer?

Moderator:  Dr. Fahad Ibnshamsah